Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

What can happen to food.

Bannister B.

Med Leg J. 2015 Sep;83(3):116-26; discussion 126-7. doi: 10.1177/0025817215595205. Epub 2015 Aug 19. No abstract available.

PMID:
26289994
2.

A 2009 cross-sectional survey of procedures for post-mortem management of highly infectious disease patients in 48 isolation facilities in 16 countries: data from EuroNHID.

Fusco FM, Scappaticci L, Schilling S, De Iaco G, Brouqui P, Maltezou HC, Brodt HR, Bannister B, Ippolito G, Puro V; EuroNHID Working Group.

Infection. 2016 Feb;44(1):57-64. doi: 10.1007/s15010-015-0831-5. Epub 2015 Aug 13.

PMID:
26267332
3.

Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.

Schilling S, Fusco FM, De Iaco G, Bannister B, Maltezou HC, Carson G, Gottschalk R, Brodt HR, Brouqui P, Puro V, Ippolito G; European Network for Highly Infectious Diseases project members.

PLoS One. 2014 Oct 28;9(10):e100401. doi: 10.1371/journal.pone.0100401. eCollection 2014.

4.

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK.

Nyland GA, McKenzie BC, Myles PR, Semple MG, Lim WS, Openshaw PJ, Read RC, Taylor BL, Brett SJ, McMenamin J, Enstone JE, Bannister B, Nicholson KG, Nguyen-Van-Tam JS.

Epidemiol Infect. 2015 Apr;143(6):1129-38. doi: 10.1017/S0950268814001873. Epub 2014 Aug 1.

5.

Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations.

Schilling S, Maltezou HC, Fusco FM, De Iaco G, Brodt HR, Bannister B, Brouqui P, Carson G, Puro V, Gottschalk R, Ippolito G; EuroNHID Study-group.

Clin Microbiol Infect. 2019 Apr;21S:e1-e5. doi: 10.1111/1469-0691.12290. Epub 2015 Jun 22. Review.

PMID:
24750421
6.

An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic.

Semple MG, Myles PR, Nicholson KG, Lim WS, Read RC, Taylor BL, Brett SJ, Openshaw PJ, Enstone JE, McMenamin J, Bannister B, Nguyen-Van-Tam JS.

PLoS One. 2013 Sep 19;8(9):e75384. doi: 10.1371/journal.pone.0075384. eCollection 2013.

7.

Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys.

Thiberville SD, Schilling S, De Iaco G, Fusco FM, Thomson G, Maltezou HC, Gottschalk R, Brodt RH, Bannister B, Puro V, Ippolito G, Brouqui P; EuroNHID Working Group.

BMC Res Notes. 2012 Sep 25;5:527. doi: 10.1186/1756-0500-5-527.

8.

Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.

De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G; European Network for Highly Infectious Diseases Working Group.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1008-16. doi: 10.1086/667729. Epub 2012 Aug 27.

PMID:
22961020
9.

Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.

Myles P, Nguyen-Van-Tam JS, Semple MG, Brett SJ, Bannister B, Read RC, Taylor BL, McMenamin J, Enstone JE, Nicholson KG, Openshaw PJ, Lim WS; Influenza Clinical Information Network FLU-CIN.

Eur Respir J. 2013 Apr;41(4):824-31. doi: 10.1183/09031936.00015512. Epub 2012 Aug 16.

10.

The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection.

Dolan GP, Myles PR, Brett SJ, Enstone JE, Read RC, Openshaw PJ, Semple MG, Lim WS, Taylor BL, McMenamin J, Nicholson KG, Bannister B, Nguyen-Van-Tam JS; Influenza Clinical Information Network (FLU-CIN).

PLoS One. 2012;7(8):e41638. Epub 2012 Aug 3.

11.

Infection control practices in facilities for highly infectious diseases across Europe.

Maltezou HC, Fusco FM, Schilling S, De Iaco G, Gottschalk R, Brodt HR, Bannister B, Brouqui P, Thomson G, Puro V, Ippolito G; EuroNHID Working Group.

J Hosp Infect. 2012 Jul;81(3):184-91. doi: 10.1016/j.jhin.2012.04.019. Epub 2012 May 29.

PMID:
22648013
12.

Biosecurity measures in 48 isolation facilities managing highly infectious diseases.

Puro V, Fusco FM, Schilling S, Thomson G, De Iaco G, Brouqui P, Maltezou HC, Bannister B, Gottschalk R, Brodt HR, Ippolito G; European Network For Highly Infectious Diseases.

Biosecur Bioterror. 2012 Jun;10(2):208-14. doi: 10.1089/bsp.2011.0098. Epub 2012 May 9.

13.

Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data.

Myles PR, Nguyen-Van-Tam JS, Lim WS, Nicholson KG, Brett SJ, Enstone JE, McMenamin J, Openshaw PJ, Read RC, Taylor BL, Bannister B, Semple MG.

PLoS One. 2012;7(4):e34428. doi: 10.1371/journal.pone.0034428. Epub 2012 Apr 3.

14.

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.

Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, Read RC, Taylor BL, Brett SJ, McMenamin J, Enstone JE, Armstrong C, Bannister B, Nicholson KG, Nguyen-Van-Tam JS; Influenza Clinical Information Network (FLU-CIN).

Thorax. 2012 Aug;67(8):709-17. doi: 10.1136/thoraxjnl-2011-200266. Epub 2012 Mar 10.

15.

Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countries.

Fusco FM, Schilling S, De Iaco G, Brodt HR, Brouqui P, Maltezou HC, Bannister B, Gottschalk R, Thomson G, Puro V, Ippolito G; EuroNHID Working Group.

BMC Infect Dis. 2012 Jan 28;12:27. doi: 10.1186/1471-2334-12-27.

16.

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease.

Brett SJ, Myles P, Lim WS, Enstone JE, Bannister B, Semple MG, Read RC, Taylor BL, McMenamin J, Nicholson KG, Nguyen-Van-Tam JS, Openshaw PJ; Influenza Clinical Information Network (FLU-CIN).

PLoS One. 2011 Apr 25;6(4):e18120. doi: 10.1371/journal.pone.0018120.

17.

Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010.

Enstone JE, Myles PR, Openshaw PJ, Gadd EM, Lim WS, Semple MG, Read RC, Taylor BL, McMenamin J, Armstrong C, Bannister B, Nicholson KG, Nguyen-Van-Tam JS.

Emerg Infect Dis. 2011 Apr;17(4):592-8. doi: 10.3201/eid1704.101679.

18.

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.

Bewick T, Myles P, Greenwood S, Nguyen-Van-Tam JS, Brett SJ, Semple MG, Openshaw PJ, Bannister B, Read RC, Taylor BL, McMenamin J, Enstone JE, Nicholson KG, Lim WS; Influenza Clinical Information Network.

Thorax. 2011 Mar;66(3):247-52. doi: 10.1136/thx.2010.151522. Epub 2011 Jan 20.

19.

Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management.

Bannister B.

Br Med Bull. 2010;95:193-225. doi: 10.1093/bmb/ldq022. Epub 2010 Aug 3. Review.

PMID:
20682627
20.

Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.

Fusco FM, Puro V, Baka A, Bannister B, Brodt HR, Brouqui P, Follin P, Gjorup IE, Gottschalk R, Hemmer R, Hoepelman IM, Jarhall B, Kutsar K, Lanini S, Lyytikainen O, Maltezou HC, Mansinho K, Marti MC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamakii H, Skinhoj P, Trilla A, Vetter N, Ippolito G.

J Hosp Infect. 2009 Sep;73(1):15-23. doi: 10.1016/j.jhin.2009.06.009. Epub 2009 Jul 31.

PMID:
19647337
21.

European concepts for the domestic transport of highly infectious patients.

Schilling S, Follin P, Jarhall B, Tegnell A, Lastilla M, Bannister B, Maria Fusco F, Biselli R, Brodt HR, Puro V.

Clin Microbiol Infect. 2009 Aug;15(8):727-33. doi: 10.1111/j.1469-0691.2009.02871.x. Epub 2009 Jun 12. Review.

22.

Training health care workers to face highly infectious diseases.

Bannister B, Prygodzicz A, Ippolito G; ETIDE Working Group.

Clin Microbiol Infect. 2009 Aug;15(8):740-2. doi: 10.1111/j.1469-0691.2009.02872.x. Epub 2009 May 28. Review.

23.

EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey.

Fusco FM, Schilling S, Puro V, Brodt HR, Follin P, Jarhall B, Bannister B, Maltezou HC, Thomson G, Brouqui P, Ippolito G; EuroNHID Study Group.

Clin Microbiol Infect. 2009 Aug;15(8):711-9. doi: 10.1111/j.1469-0691.2009.02874.x. Epub 2009 May 28. Review.

24.

Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.

Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, Gottschalk R, Hemmer R, Maltezou HC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamäki H, Skinhoj P, Ippolito G; EUNID Working Group.

Lancet Infect Dis. 2009 May;9(5):301-11. doi: 10.1016/S1473-3099(09)70070-2.

PMID:
19393960
25.

Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases.

Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G; EUNID Working Group.

Lancet Infect Dis. 2009 Jan;9(1):45-56. doi: 10.1016/S1473-3099(08)70304-9. Review.

PMID:
19095195
26.

A curriculum for training healthcare workers in the management of highly infectious diseases.

Baka A, Fusco FM, Puro V, Vetter N, Skinhoj P, Ott K, Siikamaki H, Brodt HR, Gottschalk R, Follin P, Bannister B, De Carli G, Nisii C, Heptonstall J, Ippolito G; European Network of Infectious Diseases.

Euro Surveill. 2007 Jun 1;12(6):E5-6. Review.

PMID:
17991402
27.

Management of vivax malaria with primaquine.

Beeching NJ, Lalloo DG, Bannister BA.

J Infect. 2007 Sep;55(3):282. Epub 2007 Jul 2. Review. No abstract available.

PMID:
17604840
28.

The role of standby emergency medication for falciparum malaria: current opinion.

Bannister B, Hatz C, Toovey S, Price R, Zuckerman JN.

Travel Med Infect Dis. 2004 Aug-Nov;2(3-4):119-26.

PMID:
17291973
29.

Malaria in the UK: new prevention guidelines for UK travellers.

Bannister B.

Br J Gen Pract. 2007 Jan;57(534):4-6. No abstract available.

30.

New guidelines on malaria prevention: A summary.

Swales CA, Chiodini PL, Bannister BA; Health Protection Agency Advisory Committee on Malaria Prevention in UK Travellers.

J Infect. 2007 Feb;54(2):107-10.

PMID:
17228414
31.

UK malaria treatment guidelines.

Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers.

J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.

PMID:
17215045
32.

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.

Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA, Lipman MC.

Thorax. 2004 Aug;59(8):704-7.

33.

The public health response to a case of Lassa fever in London in 2000.

Crowcroft NS, Meltzer M, Evans M, Shetty N, Maguire H, Bahl M, Gair R, Brink N, Lockwood D, Gregor S, Jones J, Nicoll A, Gopal R, Brown D, Bannister B.

J Infect. 2004 Apr;48(3):221-8.

PMID:
15001300
34.

Malaria prophylaxis for long-term travellers.

Hughes C, Tucker R, Bannister B, Bradley DJ; Health Protection Agency Advisory Committee on Malaria Prevention for UK Travellers.

Commun Dis Public Health. 2003 Sep;6(3):200-8. Review.

PMID:
14708269
35.

Guidelines for malaria prevention in travellers from the United Kingdom for 2003.

Bradley DJ, Bannister B; Health Protection Agency Advisory Committee on Malaria Prevention for UK Travellers.

Commun Dis Public Health. 2003 Sep;6(3):180-99.

PMID:
14708268
36.

Malaria 2003: the malaria parasite is still evolving, but so are the options for prophylaxis.

Bannister B.

Commun Dis Public Health. 2003 Sep;6(3):170-1. No abstract available.

PMID:
14708265
37.

Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.

Barry SM, Lipman MC, Bannister B, Johnson MA, Janossy G.

J Infect Dis. 2003 Jan 15;187(2):243-50. Epub 2002 Dec 19.

PMID:
12552448
38.

Focal testicular infarction from laparoscopic inguinal hernia repair.

Mincheff T, Bannister B, Zubel P.

JSLS. 2002 Jul-Sep;6(3):211-3.

39.

Trichinellosis acquired in the United Kingdom.

Milne LM, Bhagani S, Bannister BA, Laitner SM, Moore P, Eza D, Chiodini PL.

Epidemiol Infect. 2001 Oct;127(2):359-63.

40.

Guidelines for malaria prevention in travellers from the United Kingdom for 2001.

Bradley DJ, Bannister B; Advisory Committee on Malaria Prevention for UK Travellers.

Commun Dis Public Health. 2001 Jun;4(2):84-101.

PMID:
11525012
41.

New guidelines on malaria prevention.

Bannister B.

Commun Dis Public Health. 2001 Jun;4(2):82-3. No abstract available.

PMID:
11525011
42.

Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment.

Davies AP, Billington OJ, Bannister BA, Weir WR, McHugh TD, Gillespie SH.

J Infect. 2000 Sep;41(2):184-7.

PMID:
11023769
43.

Review of 26 years' hospital admissions for chickenpox in North London.

Bovill B, Bannister B.

J Infect. 1998 Jan;36 Suppl 1:17-23.

PMID:
9514104
44.

Practicalities of warfare required service personnel to be vaccinated against anthrax.

Blain P, Lightfoot N, Bannister B.

BMJ. 1998 Oct 17;317(7165):1077-8. No abstract available.

45.

A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction.

Hassan IS, Bannister BA, Akbar A, Weir W, Bofill M.

Clin Immunol Immunopathol. 1998 Apr;87(1):60-7.

PMID:
9576011
46.

Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995.

Hawrami K, Hart IJ, Pereira F, Argent S, Bannister B, Bovill B, Carrington D, Ogilvie M, Rawstorne S, Tryhorn Y, Breuer J.

J Clin Microbiol. 1997 Nov;35(11):2807-9.

47.

Bacterial superinfection in chickenpox. Children are probably more susceptible...

Bovill BA, Bannister BA.

BMJ. 1996 Nov 2;313(7065):1145. No abstract available.

48.

Liver function tests in adults with Plasmodium falciparum infection.

Davies MP, Brook GM, Weir WR, Bannister B, Tibbs C.

Eur J Gastroenterol Hepatol. 1996 Sep;8(9):873-5.

PMID:
8889453
49.

Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.

Peck RW, Crome P, Wood MJ, McKendrick MW, Bannister B, Mandal BK, Crooks RJ.

J Antimicrob Chemother. 1996 Mar;37(3):583-97.

PMID:
9182115
50.

Acute transverse myelitis associated with Chlamydia psittaci infection.

Crook T, Bannister B.

J Infect. 1996 Mar;32(2):151-2.

PMID:
8708374

Supplemental Content

Loading ...
Support Center